Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents-Reference-Cited by-同舟云学术

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents

Published:2013-06-15 Issue:4 Volume:162 Page:483-488
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Chen Christine I.¹,Masih-Khan Esther¹,Jiang Haiyan²,Rabea Ahmed¹,Cserti-Gazdewich Christine³,Jimenez-Zepeda Victor H.¹,Chu Chia-Min¹,Kukreti Vishal¹,Trudel Suzanne¹,Tiedemann Rodger¹,Tsang Richard⁴,Reece Donna E.¹

Affiliation:

1. Department of Medical Oncology and Haematology; Princess Margaret Cancer Centre; Toronto; ON; Canada

2. Department of Biostatistics; Princess Margaret Cancer Centre; Toronto; ON; Canada

3. Department of Transfusion Services; Toronto General Hospital; Toronto; ON; Canada

4. Department of Radiation Oncology; Princess Margaret Cancer Centre; Toronto; ON; Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12414/fullpdf

Reference17 articles.

1. Proteasome inhibitors: a novel class of potent and effective antitumor agents;Adams;Cancer Research,1999

2. Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p);Avet-Loiseau;Journal of Clinical Oncology,2010

3. Adjusting for multiple testing - when and how?;Bender;Journal of Clinical Epidemiology,2011

4. Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome;Demo;Cancer Research,2007

5. International uniform response criteria for multiple myeloma;Durie;Leukemia,2006

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroradiology of acute pathologies in adults with hematologic malignancies: a pictorial review;Quantitative Imaging in Medicine and Surgery;2023-11

2. Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case;Frontiers in Immunology;2023-10-13

3. Central nervous system manifestations as initial presentation of plasma cell disorders: Differential management of 3 cases based on disease extent;Current Problems in Cancer: Case Reports;2023-09

4. Sphenoid bone localization in the setting of highly aggressive and refractory Multiple Myeloma: A case report;Journal of Medical Imaging and Radiation Sciences;2023-09

5. A Rare Cause of Extreme Leukocytosis: Primary Plasma Cell Leukemia with High-risk Cytogenetics;2023-08-30